Testing a new imaging tool for esophageal cancer screening
Part of Cancer clinical trials.
This study tests a new imaging technology (optical biopsy) that may help doctors find early signs of esophageal cancer during a routine endoscopy. It is for people who are already scheduled for a screening procedure with a special dye (Lugol's chromoendoscopy).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be scheduled for a routine screening for esophageal cancer (using a dye called Lugol's chromoendoscopy)
- Be willing to sign a consent form
- Not be allergic to the fluorescent dye used in the study (proflavine hemisulfate)
- Not have a large or advanced tumor in the esophagus that cannot be treated with endoscopy
- Not be pregnant or breastfeeding, and have no bleeding problems or serious health issues that prevent a sedated endoscopy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special dye and camera imaging while you have surgery or a biopsy to remove a mouth lesion. The goal is to better visualize the lesion during the operation, which may help doctors guide care more accurately.
This study tests a “precision optical” method to help guide an oral biopsy in people with abnormal or potentially cancerous mouth spots. It may help clinicians target the right area to sample, making diagnosis more accurate.
This study tests a special endoscope that gives a close-up view of esophageal cells, to see if it can accurately spot early cancers or pre-cancerous changes. If you are already scheduled for a standard procedure or have a detected spot in your esophagus, this might help guide your treatment.
This study compares different special camera techniques during colonoscopy to see which best finds early abnormal (pre-cancer) changes in people with long-term ulcerative colitis. It may help doctors improve how they screen and monitor your colon over time.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial looks at a prevention treatment to stop esophagus abnormal growth (pre-cancer or very early cancer) from coming back after successful endoscopic submucosal dissection. It focuses on people whose esophagus lining shows a “speckled” pattern on a special iodine test, which may mean higher risk of recurrence.
Hear when a new Suspected or Known Squamous Cell Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.